Points for discussion

• What is a value share-based partnership & how can it inspire long term success?
• Forging collaborations with academic institutions to propel innovation
• How platform development can maximize the chances of therapeutic success in the clinic & commercially

Agenda

5:00pm Panel

5:40pm Q&A

Speakers:

Eytan Abraham, Vice President & Business Head, Cell Therapy & Gene Therapy, Nucleic Acids

Julie Allickson, Associate Professor of Regenerative Medicine, Mayo Clinic

John Kerwin, Technical Head, Gene Therapy, Resilence

Carlos Candido, Vice President External Manufacturing & Supply Chain, Be Biopharma